1. Sewry CA, Jimenez-Mallebrera C, Muntoni F. Congenital myopathies. Curr Opin Neurol. 2008; 21:569–575. PMID:
18769251.
Article
2. Choi YC. Congenital dystrophies and myopathies. In : Lisak RP, Truong D, Carroll WM, Bhidayasiri R, editors. International Neurology. 2nd ed. Hoboken (NJ): John Wiley & Sons;2016. p. 485–489. .
3. North KN, Wang CH, Clarke N, Jungbluth H, Vainzof M, Dowling JJ, et al. Approach to the diagnosis of congenital myopathies. Neuromuscul Disord. 2014; 24:97–116. PMID:
24456932.
Article
4. Kaplan JC, Hamroun D. The 2016 version of the gene table of monogenic neuromuscular disorders (nuclear genome). Neuromuscul Disord. 2015; 25:991–1020. PMID:
27563712.
Article
5. Maggi L, Scoto M, Cirak S, Robb SA, Klein A, Lillis S, et al. Congenital myopathies--clinical features and frequency of individual subtypes diagnosed over a 5-year period in the United Kingdom. Neuromuscul Disord. 2013; 23:195–205. PMID:
23394784.
6. Colombo I, Scoto M, Manzur AY, Robb SA, Maggi L, Gowda V, et al. Congenital myopathies: natural history of a large pediatric cohort. Neurology. 2015; 84:28–35. PMID:
25428687.
Article
7. Amburgey K, McNamara N, Bennett LR, McCormick ME, Acsadi G, Dowling JJ. Prevalence of congenital myopathies in a representative pediatric united states population. Ann Neurol. 2011; 70:662–665. PMID:
22028225.
Article
8. Norwood FL, Harling C, Chinnery PF, Eagle M, Bushby K, Straub V. Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. Brain. 2009; 132:3175–3186. PMID:
19767415.
Article
9. Amburgey K, Bailey A, Hwang JH, Tarnopolsky MA, Bonnemann CG, Medne L, et al. Genotype-phenotype correlations in recessive RYR1-related myopathies. Orphanet J Rare Dis. 2013; 8:117. PMID:
23919265.
Article
10. Park HJ, Jang H, Kim JH, Lee JH, Shin HY, Kim SM, et al. Discovery of pathogenic variants in a large Korean cohort of inherited muscular disorders. Clin Genet. 2017; 91:403–410. PMID:
27363342.
Article
11. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17:405–424. PMID:
25741868.
Article
12. Wu S, Ibarra MC, Malicdan MC, Murayama K, Ichihara Y, Kikuchi H, et al. Central core disease is due to RYR1 mutations in more than 90% of patients. Brain. 2006; 129:1470–1480. PMID:
16621918.
Article
13. Broman M, Islander G, Müller CR, Ranklev-Twetman E. Malignant hyperthermia and central core disease causative mutations in Swedish patients. Acta Anaesthesiol Scand. 2007; 51:50–53. PMID:
17081152.
Article
14. Chae JH, Vasta V, Cho A, Lim BC, Zhang Q, Eun SH, et al. Utility of next generation sequencing in genetic diagnosis of early onset neuromuscular disorders. J Med Genet. 2015; 52:208–216. PMID:
25635128.
Article
15. Klein A, Jungbluth H, Clement E, Lillis S, Abbs S, Munot P, et al. Muscle magnetic resonance imaging in congenital myopathies due to ryanodine receptor type 1 gene mutations. Arch Neurol. 2011; 68:1171–1179. PMID:
21911697.
Article
16. Jeong SK, Kim DC, Cho YG, Sunwoo IN, Kim DS. A double mutation of the ryanodine receptor type 1 gene in a malignant hyperthermia family with multiminicore myopathy. J Clin Neurol. 2008; 4:123–130. PMID:
19513315.
Article
17. Lee H, Kim DC, Lee JH, Cho YG, Lee HS, Choi SI, et al. [Molecular genetic analysis of the ryanodine receptor gene (RYR1) in Korean malignant hyperthermia families]. Korean J Lab Med. 2010; 30:702–710. PMID:
21157159.
Article
18. Lee JS, Lim BC, Kim KJ, Hwang YS, Seong MW, Park SS, et al. Rare coincidence of familial central core disease and hemophagocytic lymphohistiocytosis. Pediatr Int. 2014; 56:e88–e91. PMID:
25521991.
Article
19. Jung NY, Park YE, Shin JH, Lee CH, Jung DS, Kim DS. Mild clinical features and histopathologically atypical cores in two Korean families with central core disease harboring RYR1 mutations at the C-terminal region. J Clin Neurol. 2015; 11:97–101. PMID:
25628744.
20. Kim DC, Kim DS. Identification of G7304A mutation in the ryanodine receptor type 1 gene in a patient with malignant hyperthermia and an extended pedigree study in a Korean malignant hyperthermia family. Korean J Anesthesiol. 2003; 44:56–64.
Article
21. Monnier N, Romero NB, Lerale J, Landrieu P, Nivoche Y, Fardeau M, et al. Familial and sporadic forms of central core disease are associated with mutations in the C-terminal domain of the skeletal muscle ryanodine receptor. Hum Mol Genet. 2001; 10:2581–2592. PMID:
11709545.
Article
22. Snoeck M, van Engelen BG, Küsters B, Lammens M, Meijer R, Molenaar JP, et al. RYR1-related myopathies: a wide spectrum of phenotypes throughout life. Eur J Neurol. 2015; 22:1094–1112. PMID:
25960145.
Article
23. Klein A, Lillis S, Munteanu I, Scoto M, Zhou H, Quinlivan R, et al. Clinical and genetic findings in a large cohort of patients with ryanodine receptor 1 gene-associated myopathies. Hum Mutat. 2012; 33:981–988. PMID:
22473935.
Article
24. Dlamini N, Voermans NC, Lillis S, Stewart K, Kamsteeg EJ, Drost G, et al. Mutations in RYR1 are a common cause of exertional myalgia and rhabdomyolysis. Neuromuscul Disord. 2013; 23:540–548. PMID:
23628358.
Article